Nitric oxide in patients with schizophrenia: the relationship with the severity of illness and the antipsychotic treatment

Bibliography

• Forstermann U, Boissel JP, Kleinert H. Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J 1998;12(10):773-90
   PubMed Web of Science ®Google Scholar
• Vincent SR. Nitric oxide neurons and neurotransmission. Prog Neurobiol 2010;90(2):246-55
   PubMed Web of Science ®Google Scholar
• Akbarian S, Bunney WE Jr, Potkin SG, Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch Gen Psychiatry 1993;50(3):169-77
   PubMedGoogle Scholar
• Issy AC, Lazzarini M, Szawka RE, Nitric oxide synthase inhibitors improve prepulse inhibition responses of Wistar rats. Behav Brain Res 2011;217(2):416-23
   PubMedGoogle Scholar
• Bitanihirwe BK, Woo TU. Oxidative stress in schizophrenia: an integrated approach. Neurosci Biobehav Rev 2011;35(3):878-93
   PubMed Web of Science ®Google Scholar
• Palsson E, Finnerty N, Fejgin K, Increased cortical nitric oxide release after phencyclidine administration. Synapse 2009;63(12):1083-8
   PubMedGoogle Scholar
• Cui H NN, Yanagi M, Fukutake M, A putative cis-acting polymorphism in the NOS1 gene is associated with schizophrenia and NOS1 immunoreactivity in the postmortem brain. Schizophr Res 2011;121:172-8
   Google Scholar
• Benzing WC, Mufson EJ. Increased number of NADPH-d-positive neurons within the substantia innominata in Alzheimer's disease. Brain Res 1995;670(2):351-5
   PubMedGoogle Scholar
• Heales SJ, Bolanos JP, Stewart VC, Nitric oxide, mitochondria and neurological disease. Biochim Biophys Acta 1999;1410(2):215-28
   PubMed Web of Science ®Google Scholar
• Suzuki E, Nakaki T, Nakamura M, Miyaoka H. Plasma nitrate levels in deficit versus non-deficit forms of schizophrenia. J Psychiatry Neurosci 2003;28(4):288-92
   PubMed Web of Science ®Google Scholar
• Kim YK, Paik JW, Lee SW, Increased plasma nitric oxide level associated with suicide attempt in depressive patients. Prog Neuropsychopharmacol Biol Psychiatry 2006;30(6):1091-6
   PubMedGoogle Scholar
• Karolewicz B, Szebeni K, Stockmeier CA, Low nNOS protein in the locus coeruleus in major depression. J Neurochem 2004;91(5):1057-66
   PubMed Web of Science ®Google Scholar
• Vannacci A, Ravaldi C, Giannini L, Increased nitric oxide production in eating disorders. Neurosci Lett 2006;399(3):230-3
   PubMedGoogle Scholar
• Andreazza AC, Kauer-Sant'anna M, Frey BN, Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disord 2008;111(2-3):135-44
   PubMed Web of Science ®Google Scholar
• Bernstein HG, Bogerts B, Keilhoff G. The many faces of nitric oxide in schizophrenia. A review. Schizophr Res 2005;78(1):69-86
   PubMedGoogle Scholar
• Xing G, Chavko M, Zhang LX, Decreased calcium-dependent constitutive nitric oxide synthase (cNOS) activity in prefrontal cortex in schizophrenia and depression. Schizophr Res 2002;58(1):21-30
   PubMedGoogle Scholar
• Baba H, Suzuki T, Arai H, Emson PC. Expression of nNOS and soluble guanylate cyclase in schizophrenic brain. Neuroreport 2004;15(4):677-80
   PubMed Web of Science ®Google Scholar
• Zhang J. Nitric oxide synthase assays. Curr Protoc Pharmacol 2001; Chapter 2:Unit2 4
   Google Scholar
• Lundberg JO, Weitzberg E, Gladwin MT. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 2008;7(2):156-67
   PubMed Web of Science ®Google Scholar
• Dondorp AM, Planche T, de Bel EE, Nitric oxides in plasma, urine, and cerebrospinal fluid in patients with severe falciparum malaria. Am J Trop Med Hyg 1998;59(3):497-502
   PubMedGoogle Scholar
• Zoroglu SS, Herken H, Yurekli M, The possible pathophysiological role of plasma nitric oxide and adrenomedullin in schizophrenia. J Psychiatr Res 2002;36(5):309-15
   PubMed Web of Science ®Google Scholar
• Lee BH, Kim YK. Reduced plasma nitric oxide metabolites before and after antipsychotic treatment in patients with schizophrenia compared to controls. Schizophr Res 2008;104(1-3):36-43
   PubMed Web of Science ®Google Scholar
• Hou Y, Wu CF, Yang JY, Effects of clozapine, olanzapine and haloperidol on nitric oxide production by lipopolysaccharide-activated N9 cells. Prog Neuropsychopharmacol Biol Psychiatry 2006;30(8):1523-8
   PubMedGoogle Scholar
• Ramirez J, Garnica R, Boll MC, Low concentration of nitrite and nitrate in the cerebrospinal fluid from schizophrenic patients: a pilot study. Schizophr Res 2004;68(2-3):357-61
   PubMed Web of Science ®Google Scholar
• Taneli F, Pirildar S, Akdeniz F, Serum nitric oxide metabolite levels and the effect of antipsychotic therapy in schizophrenia. Arch Med Res 2004;35(5):401-5
   PubMed Web of Science ®Google Scholar
• Yilmaz N, Herken H, Cicek HK, Increased levels of nitric oxide, cortisol and adrenomedullin in patients with chronic schizophrenia. Med Princ Pract 2007;16(2):137-41
   PubMedGoogle Scholar
• Nakano Y, Yoshimura R, Nakano H, Association between plasma nitric oxide metabolites levels and negative symptoms of schizophrenia: a pilot study. Hum Psychopharmacol 2010;25(2):139-44
   PubMed Web of Science ®Google Scholar
• Reif A, Jacob CP, Rujescu D, Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans. Arch Gen Psychiatry 2009;66(1):41-50
   PubMedGoogle Scholar
• Ghasemi A, Syedmoradi L, Momenan AA, The influence of cigarette and qalyan (hookah) smoking on serum nitric oxide metabolite concentration. Scand J Clin Lab Invest 2010;70(2):116-21
   PubMed Web of Science ®Google Scholar
• Shen W, Hintze TH, Wolin MS. Nitric oxide. An important signaling mechanism between vascular endothelium and parenchymal cells in the regulation of oxygen consumption. Circulation 1995;92(12):3505-12
   PubMedGoogle Scholar
• Deliconstantinos G, Villiotou V. NO synthase and xanthine oxidase activities of rabbit brain synaptosomes: peroxynitrite formation as a causative factor of neurotoxicity. Neurochem Res 1996;21:51-6
   PubMedGoogle Scholar
• Klamer D, Engel JA, Svensson L. The neuronal selective nitric oxide synthase inhibitor, Nomega-propyl-L-arginine, blocks the effects of phencyclidine on prepulse inhibition and locomotor activity in mice. Eur J Pharmacol 2004;503(1-3):103-7
   PubMedGoogle Scholar
• Wass C, Klamer D, Fejgin K, Palsson E. The importance of nitric oxide in social dysfunction. Behav Brain Res 2009;200(1):113-16
   PubMedGoogle Scholar
• Wass C, Svensson L, Fejgin K, Nitric oxide synthase inhibition attenuates phencyclidine-induced disruption of cognitive flexibility. Pharmacol Biochem Behav 2008;89(3):352-9
   PubMedGoogle Scholar
• Chaudhry IB, Hallak J, Husain N, Minocycline benefits negative symptoms in early schizophrenia; a randomised double-blind placebo-controlled clinical trial in patients on standard treatment. J Psychopharmacol 2012; Epub ahead of print
   Google Scholar
• Retz W, Reif A, Freitag CM, Association of a functional variant of neuronal nitric oxide synthase gene with self-reported impulsiveness, venturesomeness and empathy in male offenders. J Neural Transm 2010;117(3):321-4
   PubMed Web of Science ®Google Scholar
• Ralt D. Does NO metabolism play a role in the effects of vegetables in health? Nitric oxide formation via the reduction of nitrites and nitrates. Med Hypotheses 2009;73(5):794-6
   PubMedGoogle Scholar
• Brown AS. The environment and susceptibility to schizophrenia. Prog Neurobiol 2011;93(1):23-58
   PubMed Web of Science ®Google Scholar